Jamie Christensen - 18 Dec 2023 Form 4 Insider Report for Mirati Therapeutics, Inc.

Role
EVP & Chief Scientific Officer
Signature
/s/ John Moriarty, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
18 Dec 2023
Net transactions value
-$137,252
Form type
4
Filing time
19 Dec 2023, 16:59:08 UTC
Previous filing
12 Sep 2023
Next filing
03 Jan 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Sale $137,252 -2,387 -1.7% $57.50 141,645 18 Dec 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares sold by the Company to satisfy the tax withholding obligation associated with the vesting of a portion of the performance stock units (PSUs) granted on June 25, 2021.